Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression

Citation
Jt. Kimata et al., Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression, NAT MED, 5(5), 1999, pp. 535-541
Citations number
45
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Journal title
NATURE MEDICINE
ISSN journal
10788956 → ACNP
Volume
5
Issue
5
Year of publication
1999
Pages
535 - 541
Database
ISI
SICI code
1078-8956(199905)5:5<535:ECAASI>2.0.ZU;2-J
Abstract
Genetic variants of human and simian immunodeficiency virus (HIV and SIV) t hat evolve during the course of infection and progression to AIDS are pheno typically and antigenically distinct from their progenitor viruses present at early stages of infection. However, it has been unclear how these late v ariants, which are typically T-cell tropic, cytopathic and resistant to neu tralizing antibodies, influence the development of clinical AIDS. To addres s this, we infected macaques with cloned SIVs representing prototype varian ts from early-, intermediate- and late-stage infection having biological ch aracteristics typical of viruses found at similar stages of HIV infection i n humans. These studies demonstrate that sequential, phenotypic and antigen ic variants represent viruses that have become increasingly fit for replica tion in the host, and our data support the hypothesis that emerging variant s have increased pathogenicity and drive disease progression in SIV and HIV infection.